CUSIP: 42225K106
Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
14,584,461
-
Share change
-
+1,813,654
-
Total reported value
-
$471,767,432
-
Put/Call ratio
-
60%
-
Price per share
-
$32.35
-
Number of holders
-
138
-
Value change
-
+$62,096,998
-
Number of buys
-
88
-
Number of sells
-
51
Quarterly Holders Quick Answers
What is CUSIP 42225K106?
CUSIP 42225K106 identifies HIIQ - HEALTH INS INNOVATIONS INC - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2018
-
Previous quarter:
Q1 2018
Recent filing periods for CUSIP 42225K106:
Institutional Holders of HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) as of Q2 2018
As of 30 Jun 2018,
HEALTH INS INNOVATIONS INC - COM CL A (HIIQ) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,584,461 shares.
The largest 10 holders included
Lyon Street Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, P2 Capital Partners, LLC, TimesSquare Capital Management, LLC, BlackRock Inc., CANNELL CAPITAL LLC, Capital World Investors, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Marshall Wace North America L.P., and ASHFORD CAPITAL MANAGEMENT INC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.